Wells Fargo Upgrades ResMed (RMD) to Market Perform; Shares Fairly Valued
Tweet Send to a Friend
Wells Fargo upgrades ResMed Inc. (NYSE: RMD) from Underperform to Market Perform. Valuation range increased from $45-47 to $53-58.
Wells ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wells ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
